Logo image of NICE

NICE LTD - SPON ADR (NICE) Stock Analyst Earnings Estimates

NASDAQ:NICE - Nasdaq - US6536561086 - ADR - Currency: USD

142.34  -2.31 (-1.6%)

After market: 142.5 +0.16 (+0.11%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
NICE revenue by date.NICE revenue by date.
2.181B
13.54%
2.378B
9.00%
2.735B
15.05%
2.983B
9.06%
3.184B
6.74%
3.523B
10.65%
EBITDA
YoY % growth
NICE ebitda by date.NICE ebitda by date.
511.767M
13.79%
616.574M
20.48%
754.141M
22.31%
1.022B
35.52%
1.092B
6.85%
1.131B
3.57%
EBIT
YoY % growth
NICE ebit by date.NICE ebit by date.
335.221M
26.18%
449.214M
34.01%
549.121M
22.24%
943.7M
71.86%
1.021B
8.19%
1.126B
10.28%
Operating Margin
NICE operating margin by date.NICE operating margin by date.
15.37%18.89%20.08%31.64%32.07%31.96%
EPS
YoY % growth
NICE eps by date.NICE eps by date.
7.80
16.89%
9.00
15.34%
11.39
26.51%
12.77
12.13%
13.93
9.14%
15.47
11.04%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
3.13
15.64%
3.29
11.45%
3.43
11.04%
3.34
13.53%
3.42
9.39%
3.65
11.16%
3.86
12.34%
Revenue
Q2Q % growth
727.71M
9.53%
752.05M
9.00%
803.41M
11.34%
805.85M
15.09%
816.37M
12.18%
842.09M
11.97%
882.2M
9.81%
EBITDA
Q2Q % growth
255.94M
10.27%
270.17M
-9.47%
273.66M
-24.15%
271.42M
41.36%
272.03M
6.29%
299.37M
10.81%
323.95M
18.38%
EBIT
Q2Q % growth
227.65M
76.71%
242M
70.19%
262.75M
68.65%
253.95M
70.94%
259.19M
13.85%
276.5M
14.26%
295.17M
12.34%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
2.94
11.24%
2.97-0.03-1.17%
Q4 2024
Q2Q % growth
3.09
27.97%
3.090.00-0.07%
Q3 2024
Q2Q % growth
2.95
26.87%
2.800.145.16%
Q2 2024
Q2Q % growth
2.70
23.94%
2.690.010.40%
Q1 2024
Q2Q % growth
2.64
27.09%
2.560.083.24%
Q4 2023
Q2Q % growth
2.42
15.63%
2.370.041.84%
Q3 2023
Q2Q % growth
2.32
18.23%
2.240.083.57%
Q2 2023
Q2Q % growth
2.18
14.52%
2.150.031.56%
Q1 2023
Q2Q % growth
2.08
12.78%
2.070.010.51%
Q4 2022
Q2Q % growth
2.09
17.98%
2.010.084.21%
Q3 2022
Q2Q % growth
1.97
14.29%
1.950.010.74%
Q2 2022
Q2Q % growth
1.90
18.47%
1.860.042.26%
Q1 2022
Q2Q % growth
1.84
16.88%
1.780.063.44%
Q4 2021
Q2Q % growth
1.77
7.45%
1.770.00-0.15%
Q3 2021
Q2Q % growth
1.72
19.15%
1.660.063.88%
Q2 2021
Q2Q % growth
1.61
14.60%
1.570.042.48%
Q1 2021
Q2Q % growth
1.58
14.93%
1.560.021.23%
Q4 2020
Q2Q % growth
1.65
1.90%
1.620.032.05%
Q3 2020
Q2Q % growth
1.44
8.46%
1.450.00-0.13%
Q2 2020
Q2Q % growth
1.40
9.60%
1.380.031.83%
Q1 2020
Q2Q % growth
1.37
13.56%
1.38-0.01-0.81%
Q4 2019
Q2Q % growth
1.62 1.590.031.65%
Q3 2019
Q2Q % growth
1.33 1.34-0.01-0.69%
Q2 2019
Q2Q % growth
1.28 1.270.010.92%
Q1 2019
Q2Q % growth
1.21 1.160.054.46%
NICE Yearly EPS VS EstimatesNICE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5 10 15
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
700.192M
6.20%
714.25M-14.058M-1.97%
Q4 2024
Q2Q % growth
721.6M
15.79%
730.66M-9.06M-1.24%
Q3 2024
Q2Q % growth
689.963M
14.74%
698M-8.037M-1.15%
Q2 2024
Q2Q % growth
664.4M
14.33%
677.17M-12.77M-1.89%
Q1 2024
Q2Q % growth
659.309M
15.29%
668.88M-9.571M-1.43%
Q4 2023
Q2Q % growth
623.192M
9.61%
629.04M-5.848M-0.93%
Q3 2023
Q2Q % growth
601.344M
8.40%
607.2M-5.856M-0.96%
Q2 2023
Q2Q % growth
581.113M
9.52%
590.55M-9.437M-1.60%
Q1 2023
Q2Q % growth
571.86M
8.42%
575.99M-4.13M-0.72%
Q4 2022
Q2Q % growth
568.56M
9.40%
580.38M-11.82M-2.04%
Q3 2022
Q2Q % growth
554.724M
12.33%
559.99M-5.266M-0.94%
Q2 2022
Q2Q % growth
530.581M
16.14%
533.97M-3.389M-0.63%
Q1 2022
Q2Q % growth
527.429M
15.91%
521.2M6.229M1.20%
Q4 2021
Q2Q % growth
519.694M
19.59%
506.34M13.354M2.64%
Q3 2021
Q2Q % growth
493.829M
20.50%
475.21M18.619M3.92%
Q2 2021
Q2Q % growth
456.827M
16.19%
459.08M-2.253M-0.49%
Q1 2021
Q2Q % growth
455.021M
10.86%
460M-4.979M-1.08%
Q4 2020
Q2Q % growth
434.581M
1.02%
442.01M-7.429M-1.68%
Q3 2020
Q2Q % growth
409.827M
6.10%
415.97M-6.143M-1.48%
Q2 2020
Q2Q % growth
393.18M
3.36%
399.99M-6.81M-1.70%
Q1 2020
Q2Q % growth
410.428M
8.86%
418.31M-7.882M-1.88%
Q4 2019
Q2Q % growth
430.208M 438.09M-7.882M-1.80%
Q3 2019
Q2Q % growth
386.263M 392.87M-6.607M-1.68%
Q2 2019
Q2Q % growth
380.414M 386.37M-5.956M-1.54%
Q1 2019
Q2Q % growth
377.027M 382.95M-5.923M-1.55%
NICE Yearly Revenue VS EstimatesNICE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0.04% 0.26% 0% -0.67%
Revenue-0.01% -0.24% 0.07% 0.03%